Search Results - "Olivera, Pável"

Managing venous thrombosis in a pediatric patient with short bowel and congenital nephrotic syndromes: a case report emphasizing rivaroxaban level monitoring by Bosch-Schips, Marc, Artaza, Gonzalo, Hernández-Mata, Carlos, Pérez Beltrán, Víctor, Cabello Ruiz, Vanessa, Olivera Sumire, Pável

“…Direct Oral Anticoagulants (DOACs) typically exhibit a predictable pharmacokinetic and pharmacodynamic response at a fixed dose, not necessitating monitoring…”
Get full text

Cytoplasmic crystal inclusions in lymphocytes of chronic lymphocytic leukemia by Villuendas Vázquez, Òscar, Herranz Martí, Maria José, Olivera, Pável

Get full text

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation by Olivera, Pável, Velásquez-Escandón, César, Campoy, Desirée, Flores, Katia, Canals, Tania, Johansson, Erik, Herranz, María José, Martínez, Laia, Cerezo-Manchado, Juan José, Salinas, Ramón

“…Objective During the first wave of the SARS-CoV-2 pandemic, management of anticoagulation therapy in hospitalized patients with atrial fibrillation (AF) was…”
Get full text

Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry by Cerezo Manchado, Juan José, Iturbe Hernández, Teodoro, Martínez Pacheco, María del Carmen, Gil Ortega, Ignacio, Campoy, Desirée, Canals Pernas, Tania, Martínez Serra, Laia, Flores Aparco, Katia Jessica, Velásquez Escandón, César Andrés, Martínez Francés, Antonio, Olivera, Pável

“…To describe the clinical profile, risk of complications and impact of anticoagulation in COVID-19 hospitalized patients, according to the presence of atrial…”
Get full text

Severity of gastrointestinal bleeding is similar for patients receiving direct oral anticoagulants and patients receiving vitamin K antagonists by Santamaria, Amparo, Johansson, Erik, Olivera, Pavel, Jimenez, Cesar, Jimenez, Alba, Cortina, Vicente, Cerda, Maria, Alcala-Gonzalez, Luis G, Alonso-Cotoner, Carmen

“…Background: gastrointestinal bleeding (GIB) is a common adverse event related to anticoagulation therapy. However, evidence comparing the severity, etiology…”
Get full text

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice by González-López, Tomás José, Fernández-Fuertes, Fernando, Hernández-Rivas, José Angel, Sánchez-González, Blanca, Martínez-Robles, Violeta, Alvarez-Román, María Teresa, Pérez-Rus, Gloria, Pascual, Cristina, Bernat, Silvia, Arrieta-Cerdán, Esther, Aguilar, Carlos, Bárez, Abelardo, Peñarrubia, María Jesús, Olivera, Pavel, Fernández-Rodríguez, Angeles, de Cabo, Erik, García-Frade, Luis Javier, González-Porras, José Ramón

“…Eltrombopag is safe and effective in primary chronic ITP. However, lack of clinical trials avoids a clear demonstration of its utility in newly diagnosed and…”
Get full text

Apixaban Vs Vitamin K Antagonist As Anticoagulant Therapy in Patients with End-Stage Kidney Disease on Hemodialysis and with Atrial Fibrillation by Muzio, Sofia, Artaza, Gonzalo, Benitez Hidalgo, Olga, Cortina, Vicente, Campoy, Desiree, Beas, Francisco, Bosch, Marc, Serra, Marina, Bosch, Francesc, Olivera, Pável E

“…BACKGROUND Evidence of net safety and benefit of anticoagulation for stroke prevention in patients with end-stage kidney disease (ESKD) on hemodialysis and…”
Get full text

Portal vein thrombosis in a patient with severe hemophilia B: A challenging balanced management by Benitez‐Hidalgo, Olga, Suito Alcántara, Milagros, Martinez Garcia, Maria Fernanda, Campoy, Desiree, Olivera, Pavel, Gironella Mesa, Mercedes, Juarez‐Gimenez, Juan Carlos

“…Key Clinical Message The increased life expectancy in patients with hemophilia (PwH) over the last years has raised the incidence of comorbidities, including…”
Get full text

Association of Clinical Response of ITP Patients to Eltrombopag with the Regulation of Platelet Binding to Lymphocytes by Novelli, Silvana, Zamora, Carlos, Vidal, Silvia, Valcarcel, David, Sanchez-Gonzalez, Blanca, Garcia-Pallarols, Francesc, Rodriguez, Yva, Domingo, Abel, Canet Maldonado, Marta, Olivera, Pável E

Get full text

Beyond hemostasis: the challenge of treating plasminogen deficiency. A report of three cases by Pons, Verónica, Olivera, Pável, García-Consuegra, Roberto, López-Andreoni, Laura, Martín-Begué, Nieves, García, Angel, Hidalgo, Juliana, Bosch, Francesc, Santamaría, Amparo

“…Congenital plasminogen deficiency is a rare autosomal recessive disorder, characterized by chronic mucosal membranous lesions. Although the most common…”
Get full text

Real-World Experience after Switching to FIX Extended Half Life Using Pharmacokinetic Poblacional Software and One- Compartimental MODEL by Benitez Hidalgo, Olga, Juarez Gimenez, Juan Carlos, Alvarez Roman, Maria Teresa, Romero Garrido, Jose Antonio, Gomez Del Castillo, Maria Del Carmen, Gonzalez Piñeiro, Sara, Olivera, Pável E., Bosch, Francesc, Montoro, Jose Bruno

Get full text

Management of Secondary Prevention in Venous Thromboembolism: Use of Reduced Doses of Rivaroxaban and Apixaban in Extended Therapy by Campoy, Desiree, Flores, Katia, Artaza, Gonzalo, Velasquez, César A, Canals, Tania, Johansson, Erik A, Peró, Agustí, Sierra, Jorge, Salinas, Ramón, Olivera, Pável E

“…BACKGROUND After a standard anticoagulation period (3-6 months), the risk of venous thromboembolism recurrence (RVTER) needs to be considered. Such risk is…”
Get full text

Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection by Olivera, Pável E, Campoy, Desiree, Velasquez, César A, Flores, Katia, Canals, Tania, Johansson, Erik A, Martinez, Laia, Sierra, Jorge, Cerezo, Juan Jose, Salinas, Ramón

“…Background During SARS-CoV-2 pandemic, the anticoagulant management in patients with atrial fibrillation (AF) was simplified to the use of low molecular weight…”
Get full text

The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality by Cerezo Manchado, Juan Jose, Olivera, Pável E, Lopez Abellan, María Dolores, Campoy Castaño, Desiree, Velasquez, César A, Rodriguez Rojas, Carlos, Ramos Arenas, Veronica, Flores, Katia, Cárdenas Gámez, Rubén, García de Guadiana Romualdo, Luis, Iturbe Hernandez, Teodoro, Sierra, Jorge, Salinas, Ramón

“…Introduction: The COVID-19 pandemic reflects liver damage. A study carried out in China (Guan WJ et al. N Engl J Med. 2020) reported that in more than 21% of…”
Get full text

A Spin-Off in Non Valvular Atrial Fibrilation (NVAF) and Cancer : Doacs As a Safe and Effective Alternative to the Convencional Avks by Johansson, Erik, Olivera, Pável, Canals, Tania, Bosch, Francesc, Pons, Verónica, Santamaría, Amparo, Cortina, Vicente

“…Introduction: The anticoagulation is common in patients with cancer such as treatment or prevention of venous thromboembolic events (VTE) or atrial…”
Get full text

Are Direct Oral Anticoagulants Plasma Concentrations Associated with the Risk of Postoperative Bleeding? Results from the Real Life Cohort by Olivera, Pável, Cortina, Vicente, Pons, Verónica, Canals, Tania, Johansson, Erik, Bosch, Francesc, Santamaría, Amparo

“…▪ Background The perioperative management (PM) of direct oral anticoagulants (DOACs) is controversial. The role of assessing DOAC plasma levels in order to…”
Get full text

Direct Oral Anticoagulant Vs Vitamin K Antagonist As Anticoagulant Therapy in Patients with Inherited and Acquired Thrombophilia by Olivera, Pável E, Campoy, Desirée, Velasquez, César A, Flores, Katia, Ene, Gabriela S, Canals, Tania, Artaza, Gonzalo, Subira, Maricel, Vila, Sofía, Sierra, Jorge, Salinas, Ramón

“…BACKGROUND The patients with venous thromboembolism (VTE) and thrombophilia have historically been treated with vitamin K antagonist (VKA) therapy. Nowadays,…”
Get full text

Severity of gastrointestinal bleeding is similar between patients receiving direct oral anticoagulants or vitamin K antagonists by Alcalá-González, Luis, Jiménez, César, Cortina, Vicente, Jiménez, Alba, Cerdá, María, Johansson, Erik, Olivera, Pável, Santamaría, Amparo, Alonso-Cotoner, Carmen

“…Gastrointestinal bleeding (GIB) is a common adverse event related to anticoagulation therapy. However, evidence comparing the severity, aetiology, and outcomes…”
Get full text

Anticoagulation Challenges in Hematogeriatrics: Effectiveness and Safety of Direct Oral Anticoagulants Vs Vitamin k Antagonist in Elderly with Atrial Fibrillation by Campoy, Desirée, Artaza, Gonzalo, Velasquez, César A, Canals, Tania, Johansson, Erik A, Flores, Katia, Bastidas, Gabriela, Ruiz, Silvia, Ene, Gabriela S, Comai, Alessandra, Subira, Maricel, Salinas, Ramón, Sierra, Jorge, Olivera, Pável E

“…BACKGROUND Direct oral anticoagulants (DOAC) are increasingly used in patients with Non Valvular Atrial Fibrillation (NVAF) for stroke prevention. However,…”
Get full text

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation by Olivera, Pável E, Velasquez, César A, Campoy, Desirée, Artaza, Gonzalo, Canals, Tania, Flores, Katia, Ruiz, Silvia, Comai, Alessandra, Johansson, Erik A, Ene, Gabriela S, Bastidas, Gabriela, Subira, Maricel, Sierra, Jorge, Salinas, Ramón

“…BACKGROUND Non Valvular Atrial Fibrillation (NVAF) is the most common cardiac arrhythmia among patients with cancer. Anticoagulation in this setting is…”
Get full text